Evaluation of Cumulative Prognostic Scores Based on the Systemic Inflammatory Response in Patients With Inoperable Non-Small-Cell Lung Cancer

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6601242
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prognostic Evaluation of Patients With Resectable Lung Cancer Using Systemic Inflammatory Response Parameters

Oncology Letters
Cancer ResearchOncology
2018English

Comparison of Inflammation-Based Prognostic Scores in Patients Undergoing Curative Resection for Non-Small Cell Lung Cancer

World Journal of Oncology
Cancer ResearchOncology
2018English

Neuropsychological Evaluation of Patients With Inoperable Non-Small Cell Lung Cancer Treated With Combination Chemotherapy or Radiotherapy

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1988English

Prognostic Significance of CD31 Expression in Patients With Non-Small-Cell-Lung Cancer

Advances in Lung Cancer
2016English

Prognostic Impact of Serum Transthyretin in Patients With Non‑small Cell Lung Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2019English

Cisplatin, Vinblastine, and Bleomycin in Inoperable Non-Small Cell Lung Cancer.

Thorax
PulmonaryRespiratory Medicine
1985English

Prognostic Value of BCL-2 Expression in Patients With Non-Small-Cell Lung Cancer: A Meta-Analysis and Systemic Review

OncoTargets and Therapy
OncologyPharmacology
2015English

P3.01-36 Prognostic Factors in Elderly Patients With Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Prognostic Significance of Sites of Extrathoracic Metastasis in Patients With Non-Small Cell Lung Cancer

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy